Quince Therapeutics, Inc.
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
QNCX | NDAQ
Overview
Corporate Details
- ISIN(s):
- US22053A1079
- LEI:
- Country:
- United States of America
- Address:
- 611 GATEWAY BLVD., SUITE 273, 94080 SOUTH SAN FRANCISCO
- Website:
- https://quincetx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Quince Therapeutics, Inc. is a late-stage biotechnology company focused on developing and commercializing therapeutics for rare diseases. The company's core technology is its proprietary Autologous Intracellular Drug Encapsulation (AIDE) platform, a novel drug/device combination that encapsulates drugs within a patient's own red blood cells. This delivery system is designed to improve tolerability, enhance tissue biodistribution, and reduce the adverse effects of potent medicines. Quince's lead product candidate, eDSP, is in a pivotal Phase 3 clinical trial for the treatment of Ataxia-Telangiectasia (A-T), a rare pediatric neurodegenerative disease with no currently approved therapies. The eDSP System has received Fast Track designation from the U.S. Food and Drug Administration.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Quince Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Quince Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Quince Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
